Health Canada has not approved BPC-157 as a health product or prescription drug, classifying it as an unauthorized health product
Even with an increase in spending at enrollment, HOP participation resulted in lower overall spending over time
In the usual course of things, a promising drug candidate would be ushered into human trials
These enzymes are critical for drug metabolism, influencing the bodys response to therapeutic agents
While BPC-157 is generally well-tolerated, potential side effects include: Mild gastrointestinal issues if taken on an empty stomach Changes in appetite or weight Dizziness Fatigue Headaches Research on BPC-157 is still limited, so monitoring for any adverse reactions is important although the above have never been reported to us by any user who has purchased from our site (7, 13)
You can Get Started Today